JN.1: ongoing considerations of the shifting landscape of SARS-CoV-2 variants

被引：1

作者：

Basu, Soumya ^{[1
]}

Kayal, Titirsha ^{[2
]}

Patro, Ponoop Prasad ^{[1
]}

Patnaik, Amit ^{[1
]}

机构：

[1] NIST Univ, Dept Biotechnol, Mol Biotechnol Lab, Berhampur 761008, Odisha, India

[2] Indira Gandhi Govt Med Coll & Hosp IGGMC&H, Dept Microbiol, Nagpur 440018, Maharashtra, India

来源：

关键词：

COVID-19; healthcare; mutations; spike protein; vaccine; variant;

D O I：

10.2217/fmb-2024-0010

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

页码：559 / 562

页数：4

共 20 条

[1] [Anonymous], 2023, Reuters
[2] SARS-CoV-2 (COVID-19) by the numbers
Bar-On, Yinon M.
Flamholz, Avi
Phillips, Rob
Milo, Ron
[J]. ELIFE, 2020, 9
[3] Impact of the COVID-19 pandemic on routine vaccine landscape: A global perspective
Basu, Soumya
Ashok, Gayathri
Debroy, Reetika
Ramaiah, Sudha
Livingstone, Paul
Anbarasu, Anand
[J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (01)
[4] Centre for Disease Control and Prevention, 2024, UPD COVID VACC JN 1
[5] Centre for Disease Control and Prevention, 2023, UPD SARS COV 2 VAR J
[6] Dutt A., 2023, CTR WRITES STATES NE
[7] Distinguishing features of current COVID-19 vaccines: knowns and unknowns of antigen presentation and modes of action
Heinz, Franz X.
Stiasny, Karin
[J]. NPJ VACCINES, 2021, 6 (01)
[8] Humoral immune escape by current SARS-CoV-2 variants BA.2.86 and JN.1, December 2023
Jeworowski, Lara M.
Muehlemann, Barbara
Walper, Felix
Schmidt, Marie L.
Jansen, Jenny
Krumbholz, Andi
Simon-Loriere, Etienne
Jones, Terry C.
Corman, Victor M.
Drosten, Christian
[J]. EUROSURVEILLANCE, 2024, 29 (02)
[9] Kaku Y., 2023, BIORXIV, DOI [10.1101/2023.12.08.570782v1, DOI 10.1101/2023.12.08.570782V1]
[10] SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates
Kyriakidis, Nikolaos C.
Lopez-Cortes, Andres
Vasconez Gonzalez, Eduardo
Barreto Grimaldos, Alejandra
Ortiz Prado, Esteban
[J]. NPJ VACCINES, 2021, 6 (01)